Shanghai Haohai Biological Technology Co (HKSE:06826) ROCE % : 9.43% (As of Jun. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Shanghai Haohai Biological Technology Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shanghai Haohai Biological Technology Co's annualized ROCE % for the quarter that ended in Jun. 2024 was 9.43%.

Shanghai Haohai Biological Technology Co ROCE % Historical Data

The historical data trend for Shanghai Haohai Biological Technology Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Haohai Biological Technology Co ROCE % Chart

Shanghai Haohai Biological Technology Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

8.90

4.64

6.39

3.61

7.99

Shanghai Haohai Biological Technology Co Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															8.49	7.62	7.23	9.43	7.97

Shanghai Haohai Biological Technology Co ROCE % Calculation

Shanghai Haohai Biological Technology Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	563.903	/	( ( (7696.843 - 570.948)	+	(7771.843 - 783.092) )	/ 2 )
	=	563.903	/	( (7125.895	+	6988.751)	/ 2 )
	=	563.903	/	7057.323
	=	7.99 %

Shanghai Haohai Biological Technology Co's ROCE % of for the quarter that ended in Jun. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jun. 2024 )		(Q: Mar. 2024 )		(Q: Jun. 2024 )
	=	659.62	/	( ( (7813.715 - 749.293)	+	(7796.529 - 870.203) )	/ 2 )
	=	659.62	/	( ( 7064.422	+	6926.326 )	/ 2 )
	=	659.62	/	6995.374
	=	9.43 %

(1) Note: The EBIT data used here is four times the quarterly (Jun. 2024) EBIT data.

Shanghai Haohai Biological Technology Co (HKSE:06826) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shanghai Haohai Biological Technology Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shanghai Haohai Biological Technology Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Haohai Biological Technology Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Haohai Biological Technology Co Ltd (HKSE:06826) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

5HB:Germany 688366:China

Address

No. 1386 Hongqiao Road, 23rd Floor, WenGuang Plaza, Changning District, Shanghai, CHN

Website

https://www.3healthcare.com

Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to single operating segment which is the manufacture and sale of biologicals, medical hyaluronate and intraocular lens, research and development of biological engineering and pharmaceutical products and the provision of related services. Its products are categorized into four types comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China which is the key revenue driver, the United States, the United Kingdom, and other countries.

Executives

Morgan Stanley	2201 Interest of corporation controlled by you
Dalton Investments Llc	2102 Investment manager
The Bank Of New York Mellon Corporation	2201 Interest of corporation controlled by you
Templeton Investment Counsel, Llc	2102 Investment manager
Kabouter Management Llc	2102 Investment manager
Royal Bank Of Canada	2201 Interest of corporation controlled by you
Kabouter International Insight Fund, Llc	2102 Investment manager
Prudence Investment Management (hong Kong) Limited	2102 Investment manager

Shanghai Haohai Biological Technology Co Headlines

No Headlines